Also trades as: MDCX (NASDAQ) · $vol 1M
MDCXW NASDAQ
Medicus Pharma Ltd. Common Stock
1W: -3.2%
1M: -22.7%
3M: -34.5%
YTD: -88.0%
1Y: -65.9%
$0.30
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
12 relationships12
As Filer
counterparties named
0
As Counterparty
mentioned by others
4
Rel. Types
2025-02-11
Earliest Filing
2025-12-30
Latest Filing
target: 5
partner: 3
investor: 2
acquirer: 2
Counterparties (Filed by MDCXW)
12 relationshipsCompanies named in MDCXW's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Maxim Group LLC | MMS | partner | Sales agent for at-the-market equity program | 2025-12-30 | View |
| YA II PN, Ltd. | — | investor | Existing debenture holder and party to prior Standby Equity Purchase Agreement | 2025-09-18 | View |
| Antev Limited | — | target | Target company in a securities exchange agreement for the sale of its share capital. | 2025-09-02 | View |
| Medicus Pharma Ltd. | MDCXW | acquirer | Acquirer purchasing the entire issued and to be issued share capital of Antev. | 2025-09-02 | View |
| Medicus Pharma Ltd. | MDCXW | acquirer | Acquiring Antev Ltd. in a share exchange transaction for approximately 17% equity stake and $65 million in contingent pa | 2025-06-30 | View |
| Antev Ltd. | — | target | UK-based clinical-stage drug development company being acquired by Medicus Pharma Ltd. | 2025-06-30 | View |
| Maxim Group LLC | MMS | partner | Placement agent representing the Placement Agents in the offering | 2025-06-02 | View |
| Medicus Pharma Ltd. | MDCXW | target | The Company issuing the Units and Warrants in the offering | 2025-06-02 | View |
| Medicus Pharma Ltd. | MDCXW | target | Company entering placement agency agreement for Regulation A offering | 2025-03-11 | View |
| Maxim Group LLC | MMS | partner | Representative of placement agents | 2025-03-11 | View |
| YA II PN, LTD. | — | investor | Investor in the Standby Equity Purchase Agreement | 2025-02-11 | View |
| MEDICUS PHARMA LTD. | MDCXW | target | Company issuing shares to the Investor | 2025-02-11 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-09-14 | Termination of Agreement; Exhibits | View | |
| 2026-09-11 | Unregistered Equity Sales; Exhibits | View | |
| 2026-09-03 | Material Agreement; Exhibits | Agreement | View |
| 2026-06-04 | Shareholder Vote; Exhibits | View | |
| 2026-05-27 | Material Agreement; Financial Obligation; Delisting Notice; Exhibits | Agreement | View |
| 2026-04-24 | Material Agreement; Delisting Notice; Exhibits | Agreement | View |
| 2026-03-06 | Unregistered Sales of Equity Securities; Financial Statements and Exhibits | View | |
| 2025-12-30 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
| 2025-12-08 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Regulation FD Dis | Agreement | View |
| 2025-12-01 | Departure/Election of Directors; Appointment of Officers; Regulation FD Disclosure; Financial Statem | View | |
| 2025-11-14 | Other Events; Financial Statements and Exhibits | View | |
| 2025-10-17 | Unregistered Sales of Equity Securities; Financial Statements and Exhibits | View | |
| 2025-09-18 | Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Other Events; Fin | Agreement | View |
| 2025-09-12 | Departure/Election of Directors; Appointment of Officers | View | |
| 2025-09-02 | Completion of Acquisition or Disposition of Assets; Unregistered Sales of Equity Securities; Departu | Acquisition | View |
| 2025-08-22 | Unregistered Sales of Equity Securities; Other Events; Financial Statements and Exhibits | View | |
| 2025-08-04 | Other Events; Financial Statements and Exhibits | View | |
| 2025-07-30 | Other Events | View | |
| 2025-07-23 | Submission of Matters to a Vote of Security Holders; Other Events; Financial Statements and Exhibits | View | |
| 2025-07-14 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Financial Stateme | Agreement | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR